ArticleThe Lancet. Infectious diseases2019

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.

Joke Bilcke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.